Ototoxicity, characterized by hearing loss and other auditory disturbances, is a significant adverse effect associated with ...

Q3 2024 Earnings Call Transcript November 9, 2024 Operator: Good morning, ladies and gentlemen, and welcome to Fennec ...

Platinum-based antineoplastic drugs are widely used in the treatment of solid tumors. Carboplatin is a safe and efficacious adjuvant treatment for stage I seminoma following a risk-adapted treatment ...

Location: Sheraton New York Times Square Hotel, New York City ...

We believe that their leadership, combined with Fennec’s talented employee base, will significantly accelerate our ability to build upon and seamlessly execute our commercialization strategy for ...

Abstract and Introduction Empirical Antimicrobial Therapy Against Gram-negative Pathogens Adverse Consequences Related to Combination Antimicrobial Use Conclusion References A recent retrospective ...

For further clarification, consult your healthcare provider. Generally not indicated for long-term therapy because of ototoxicity (damage to the ear) and nephrotoxicity (damage to kidney cells).

Fennec is a specialty pharmaceutical company on the market for the treatment of ototoxicity in pediatric patients with PEDMARK receiving chemotherapy and the firm anticipates it to have meaningful ...

NYHA Class IV Approval: In August 2024, scPharmaceuticals announced that the U.S. Food and Drug Administration (FDA) granted approval for FUROSCIX, expanding the indication to include New York Heart ...

Ototoxicity and glucose intolerance are rare side effects. Posture can affect the patient's response to a diuretic. Patients with CHF have enhanced renal perfusion when supine, and therefore ...

After hours: November 22 at 5:58 PM EST Loading Chart for FENC ...